OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy
Shahryar Khoshtinat Nikkhoi, Geng Li, Suha Eleya, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 28
Shahryar Khoshtinat Nikkhoi, Geng Li, Suha Eleya, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Development of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 315-331
Open Access | Times Cited: 51
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 315-331
Open Access | Times Cited: 51
Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
Minchuan Zhang, Kong‐Peng Lam, Shengli Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Minchuan Zhang, Kong‐Peng Lam, Shengli Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases
Camille Rolin, Jacques Zimmer, Carole Seguin‐Devaux
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 7, pp. 643-661
Open Access | Times Cited: 10
Camille Rolin, Jacques Zimmer, Carole Seguin‐Devaux
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 7, pp. 643-661
Open Access | Times Cited: 10
Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment
Mohamed J. Saadh, Irodakhon Rasulova, Mohammed N. A. Khalil, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155120-155120
Closed Access | Times Cited: 9
Mohamed J. Saadh, Irodakhon Rasulova, Mohammed N. A. Khalil, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155120-155120
Closed Access | Times Cited: 9
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 20
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 20
Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
HER2-Positive Breast Cancer Treatment and Resistance
Jamunarani Veeraraghavan, Carmine De Angelis, Carolina Gutiérrez, et al.
Advances in experimental medicine and biology (2025), pp. 495-525
Closed Access
Jamunarani Veeraraghavan, Carmine De Angelis, Carolina Gutiérrez, et al.
Advances in experimental medicine and biology (2025), pp. 495-525
Closed Access
Natural killer cell engagers for cancer immunotherapy
Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
Frontiers in Oncology (2025) Vol. 14
Open Access
Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
Frontiers in Oncology (2025) Vol. 14
Open Access
The role of MUC16 in tumor biology and tumor immunology in ovarian cancer
Na Yang, Xi Kathy Zhou, Yangmei Gong, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Na Yang, Xi Kathy Zhou, Yangmei Gong, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment
Xiaohan Guo, Yi Wu, Ying Xue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Xiaohan Guo, Yi Wu, Ying Xue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Harnessing immune cells to eliminate HIV reservoirs
Paula Grasberger, Abigail R. Sondrini, Kiera Clayton
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 2, pp. 62-68
Open Access | Times Cited: 4
Paula Grasberger, Abigail R. Sondrini, Kiera Clayton
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 2, pp. 62-68
Open Access | Times Cited: 4
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice
Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008295-e008295
Open Access | Times Cited: 4
Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008295-e008295
Open Access | Times Cited: 4
The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma
Shuzhan Li, Wei Dai, Ngar‐Woon Kam, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1312-1312
Open Access | Times Cited: 4
Shuzhan Li, Wei Dai, Ngar‐Woon Kam, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1312-1312
Open Access | Times Cited: 4
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Utilizing immunotherapy towards achieving a functional cure for HIV-1
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole S. Søgaard
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 187-193
Closed Access | Times Cited: 2
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole S. Søgaard
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 187-193
Closed Access | Times Cited: 2
Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics
Qian Zhang, Nan Zhang, Han Xiao, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5639-5639
Open Access | Times Cited: 6
Qian Zhang, Nan Zhang, Han Xiao, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5639-5639
Open Access | Times Cited: 6
A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab’s epitope with versatile biochemical, biological, and medical applications
Shahryar Khoshtinat Nikkhoi, Hediyeh Heydarzadeh, Venu Gopal Vandavasi, et al.
Immunologic Research (2023) Vol. 72, Iss. 1, pp. 103-118
Open Access | Times Cited: 5
Shahryar Khoshtinat Nikkhoi, Hediyeh Heydarzadeh, Venu Gopal Vandavasi, et al.
Immunologic Research (2023) Vol. 72, Iss. 1, pp. 103-118
Open Access | Times Cited: 5
Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer
Huan Tian, Bugao Guan, Hongbo Li, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 5
Huan Tian, Bugao Guan, Hongbo Li, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 5
Potent Apoptosis Induction by a Novel Trispecific B7-H3xCD16xTIGIT 2+1 Common Light Chain Natural Killer Cell Engager
Michael Ulitzka, Julia Harwardt, Britta Lipinski, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1140-1140
Open Access | Times Cited: 1
Michael Ulitzka, Julia Harwardt, Britta Lipinski, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1140-1140
Open Access | Times Cited: 1
Next generation single-domain antibodies against respiratory zoonotic RNA viruses
Iris C. Swart, W. van Gelder, Cornelis A. M. de Haan, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Iris C. Swart, W. van Gelder, Cornelis A. M. de Haan, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
Bill Liao, Christine Tumanut, Li Lin, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access
Bill Liao, Christine Tumanut, Li Lin, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access
Natural Killer Cell Cellular-based Therapeutic Options to Manage Acute Myeloid Leukemia: Prospects and Challenges
Ogochukwu Izuegbuna
Deleted Journal (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Ogochukwu Izuegbuna
Deleted Journal (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide
Ge Yang, Shahryar Khoshtinat Nikkhoi, Hajar Owji, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 75-75
Open Access
Ge Yang, Shahryar Khoshtinat Nikkhoi, Hajar Owji, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 75-75
Open Access
Polypeptides-Based Nanocarriers in Tumor Therapy
Juhua You, Yifei Guo, Zhengqi Dong
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1192-1192
Open Access
Juhua You, Yifei Guo, Zhengqi Dong
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1192-1192
Open Access
Research Progress on Peripheral Blood Biomarkers Based on PD-1/PD-L1 Inhibitors for Advanced Non-Small Cell Lung Cancer
雅楠 苗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 126-133
Closed Access
雅楠 苗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 126-133
Closed Access
